Generic antidepressant taken off the market

Article

After reviewing new data, FDA has concluded that Budeprion XL 300 mg (bupropion hydrochloride extended-release tablets), manufactured by Impax Laboratories, Inc., and marketed by Teva Pharmaceuticals USA, Inc., is not therapeutically equivalent to GlaxoSmithKline’s Wellbutrin XL 300 mg.

Recent Videos
1 expert is featured in this series.
1 expert is featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.